Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin H van Vliet

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2020
Gene Networks Constructed Through Simulated Treatment Learning can Predict Proteasome Inhibitor Benefit in Multiple MyelomaJoske Ubels, Pieter Sonneveld, Martin H van Vliet, et al.
BMC Bioinformatics|February 12, 2009
Knowledge driven decomposition of tumor expression profilesMartin H van Vliet, Lodewyk F A Wessels, Marcel J T Reinders
Plos One|October 18, 2007
Module-based outcome prediction using breast cancer compendiaMartin H van Vliet, Christiaan N Klijn, Lodewyk F A Wessels, et al.
Nature Communications|July 29, 2018
Predicting treatment benefit in multiple myeloma through simulation of alternative treatment effectsJoske Ubels, Pieter Sonneveld, Erik H van Beers, et al.
Plos One|July 19, 2012
Integration of clinical and gene expression data has a synergetic effect on predicting breast cancer outcomeMartin H van Vliet, Hugo M Horlings, Marc J van de Vijver, et al.
Experimental Hematology & Oncology|March 19, 2013
A standardized microarray assay for the independent gene expression markers in AML: EVI1 and BAALCJaap Brand, Martin H van Vliet, Leonie de Best, et al.
BMC Genomics|August 8, 2008
Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stabilityMartin H van Vliet, Fabien Reyal, Hugo M Horlings, et al.
Pharmacogenomics|January 16, 2018
Potential therapeutic and economic value of risk-stratified treatment as initial treatment of multiple myeloma in EuropeJennifer G Gaultney, Therese W Ng, Carin A Uyl-de Groot, et al.
The Journal of Molecular Diagnostics : JMD|November 5, 2020
Analytical Validation of SKY92 for the Identification of High-Risk Multiple MyelomaErik H van Beers, Daphne Huigh, Lizanne Bosman, et al.
Genetic Testing and Molecular Biomarkers|March 28, 2013
Detection of mutant NPM1 mRNA in acute myeloid leukemia using custom gene expression arraysMartin H van Vliet, Belinda Dumee, Erik Simons, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2020
Gene Networks Constructed Through Simulated Treatment Learning can Predict Proteasome Inhibitor Benefit in Multiple MyelomaJoske Ubels, Pieter Sonneveld, Martin H van Vliet, et al.
BMC Bioinformatics|February 12, 2009
Knowledge driven decomposition of tumor expression profilesMartin H van Vliet, Lodewyk F A Wessels, Marcel J T Reinders
Plos One|October 18, 2007
Module-based outcome prediction using breast cancer compendiaMartin H van Vliet, Christiaan N Klijn, Lodewyk F A Wessels, et al.
Nature Communications|July 29, 2018
Predicting treatment benefit in multiple myeloma through simulation of alternative treatment effectsJoske Ubels, Pieter Sonneveld, Erik H van Beers, et al.
Plos One|July 19, 2012
Integration of clinical and gene expression data has a synergetic effect on predicting breast cancer outcomeMartin H van Vliet, Hugo M Horlings, Marc J van de Vijver, et al.
Experimental Hematology & Oncology|March 19, 2013
A standardized microarray assay for the independent gene expression markers in AML: EVI1 and BAALCJaap Brand, Martin H van Vliet, Leonie de Best, et al.
BMC Genomics|August 8, 2008
Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stabilityMartin H van Vliet, Fabien Reyal, Hugo M Horlings, et al.
Pharmacogenomics|January 16, 2018
Potential therapeutic and economic value of risk-stratified treatment as initial treatment of multiple myeloma in EuropeJennifer G Gaultney, Therese W Ng, Carin A Uyl-de Groot, et al.
The Journal of Molecular Diagnostics : JMD|November 5, 2020
Analytical Validation of SKY92 for the Identification of High-Risk Multiple MyelomaErik H van Beers, Daphne Huigh, Lizanne Bosman, et al.
Genetic Testing and Molecular Biomarkers|March 28, 2013
Detection of mutant NPM1 mRNA in acute myeloid leukemia using custom gene expression arraysMartin H van Vliet, Belinda Dumee, Erik Simons, et al.
Pageof 3